These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 32482341)
1. Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers? Ria R; Prete F; Melaccio A; Di Meo G; Saltarella I; Solimando AG; Gurrado A; Ferraro V; Pasculli A; Sgaramella LI; Racanelli V; Vacca A; Testini M Surgery; 2021 Jan; 169(1):27-33. PubMed ID: 32482341 [TBL] [Abstract][Full Text] [Related]
2. Trends in white blood cell and platelet indices in a comparison of patients with papillary thyroid carcinoma and multinodular goiter do not permit differentiation between the conditions. Machairas N; Kostakis ID; Prodromidou A; Stamopoulos P; Feretis T; Garoufalia Z; Damaskos C; Tsourouflis G; Kouraklis G Endocr Res; 2017 Nov; 42(4):311-317. PubMed ID: 28506088 [TBL] [Abstract][Full Text] [Related]
3. Response to letter: "Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers?". Prete FP; Ria R; Gurrado A; Testini M Surgery; 2021 Apr; 169(4):996-997. PubMed ID: 33293031 [No Abstract] [Full Text] [Related]
4. Letter to the Editor: Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers? Akın T; Surel AA; Tez M Surgery; 2021 Apr; 169(4):996. PubMed ID: 32861437 [No Abstract] [Full Text] [Related]
5. Indications for surgery and significance of unrecognized cancer in endemic multinodular goiter. Lasithiotakis K; Grisbolaki E; Koutsomanolis D; Venianaki M; Petrakis I; Vrachassotakis N; Chrysos E; Zoras O; Chalkiadakis G World J Surg; 2012 Jun; 36(6):1286-92. PubMed ID: 22395348 [TBL] [Abstract][Full Text] [Related]
6. Patient outcomes following surgical management of multinodular goiter: Does multinodularity increase the risk of thyroid malignancy? Lin YS; Wu HY; Yu MC; Hsu CC; Chao TC Medicine (Baltimore); 2016 Jul; 95(28):e4194. PubMed ID: 27428220 [TBL] [Abstract][Full Text] [Related]
7. Lack of Variation in Inflammatory Hematological Parameters between Benign Nodular Goiter and Papillary Thyroid Cancer. Yaylaci S; Tosun O; Sahin O; Genc AB; Aydin E; Demiral G; Karahalil F; Olt S; Ergenc H; Varim C Asian Pac J Cancer Prev; 2016; 17(4):2321-3. PubMed ID: 27221938 [TBL] [Abstract][Full Text] [Related]
8. Circulating levels of PTEN and KLLN in papillary thyroid carcinoma: can they be considered as novel diagnostic biomarkers? Razavi SA; Modarressi MH; Yaghmaei P; Tavangar SM; Hedayati M Endocrine; 2017 Sep; 57(3):428-435. PubMed ID: 28755140 [TBL] [Abstract][Full Text] [Related]
9. Incidental thyroid cancer in toxic and nontoxic goiter: Is TSH associated with malignanCy rate? Results of a meta-analysis. Negro R; Valcavi R; Toulis KA Endocr Pract; 2013; 19(2):212-8. PubMed ID: 23186976 [TBL] [Abstract][Full Text] [Related]
11. The advantage of total thyroidectomy to avoid reoperation for incidental thyroid cancer in multinodular goiter. Giles Y; Boztepe H; Terzioglu T; Tezelman S Arch Surg; 2004 Feb; 139(2):179-82. PubMed ID: 14769577 [TBL] [Abstract][Full Text] [Related]
12. Combination of serum microRNAs and ultrasound profile as predictive biomarkers of diagnosis and prognosis for papillary thyroid microcarcinoma. Zhang Y; Pan J; Xu D; Yang Z; Sun J; Sun L; Wu Y; Qiao H Oncol Rep; 2018 Dec; 40(6):3611-3624. PubMed ID: 30542708 [TBL] [Abstract][Full Text] [Related]
13. [ANALYSIS OF THE SURGICAL TREATMENT RESULTS IN THE THYROID GLAND DISEASES]. Tarashchenko YN; Bolgov MY Klin Khir; 2015 Aug; (8):48-50. PubMed ID: 26591865 [TBL] [Abstract][Full Text] [Related]
14. The comparison of serum vascular endothelial growth factor levels between patients with metastatic and non-metastatic thyroid cancer, and patients with nontoxic multinodular goiter. Klubo-Gwiezdzinska J; Junik R; Kopczynska E; Juraniec O; Kardymowicz H Eur J Endocrinol; 2007 Oct; 157(4):521-7. PubMed ID: 17893268 [TBL] [Abstract][Full Text] [Related]
15. Preoperatively undiagnosed papillary thyroid carcinoma in patients thyroidectomized for benign multinodular goiter. Fama F; Sindoni A; Cicciu M; Polito F; Piquard A; Saint-Marc O; Gioffre-Florio M; Benvenga S Arch Endocrinol Metab; 2018; 62(2):139-148. PubMed ID: 29641730 [TBL] [Abstract][Full Text] [Related]
16. lncRNA GAS8-AS1 genetic alterations in papillary thyroid carcinoma and their clinical significance. Zhou DL; Liu Q; Xu BH; Li Y; Su X; Ye ZL; Zhang X; Peng JL; Deng L; Tang T; Shao Q; Ma JJ; Yang XH; He CY Cancer Biomark; 2020; 29(2):255-264. PubMed ID: 32675393 [TBL] [Abstract][Full Text] [Related]
17. The advantage of near-total thyroidectomy to avoid postoperative hypoparathyroidism in benign multinodular goiter. Erbil Y; Barbaros U; Salmaslioğlu A; Yanik BT; Bozbora A; Ozarmağan S Langenbecks Arch Surg; 2006 Nov; 391(6):567-73. PubMed ID: 17021791 [TBL] [Abstract][Full Text] [Related]
18. Detection Rate of Thyroid Papillary Micro-carcinoma in Multinodular Goiter Surgery. Ozer B; Sit M; Aktas G; Keyif F; Bolat F; Erkol H J Coll Physicians Surg Pak; 2019 Apr; 29(4):353-355. PubMed ID: 30925960 [TBL] [Abstract][Full Text] [Related]
19. Characteristics of well-differentiated thyroid cancer associated with multinodular goiter. Cheng SP; Liu CL; Tzen CY; Yang TL; Jeng KS; Liu TP; Lee JJ Langenbecks Arch Surg; 2008 Sep; 393(5):729-32. PubMed ID: 18404277 [TBL] [Abstract][Full Text] [Related]